These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33624188)
1. EGFR-specific single-chain variable fragment antibody-conjugated Fe Lu Y; Huang J; Li F; Wang Y; Ding M; Zhang J; Yin H; Zhang R; Ren X MAGMA; 2021 Aug; 34(4):581-591. PubMed ID: 33624188 [TBL] [Abstract][Full Text] [Related]
2. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer. Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366 [TBL] [Abstract][Full Text] [Related]
3. HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth. Lu Y; Wang Y; Zhang M; Liu L; Li F; Zhang J; Ye M; Zhao H; Zhao J; Yan B; Yang A; Zhang R; Li X; Ren X Oncotarget; 2016 Apr; 7(17):23594-607. PubMed ID: 26988752 [TBL] [Abstract][Full Text] [Related]
4. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody. Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and application of strawberry-like Fe3O4-Au nanoparticles as CT-MR dual-modality contrast agents in accurate detection of the progressive liver disease. Zhao HY; Liu S; He J; Pan CC; Li H; Zhou ZY; Ding Y; Huo D; Hu Y Biomaterials; 2015 May; 51():194-207. PubMed ID: 25771010 [TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer. Ashton JR; Gottlin EB; Patz EF; West JL; Badea CT PLoS One; 2018; 13(11):e0206950. PubMed ID: 30408128 [TBL] [Abstract][Full Text] [Related]
7. Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer. Wu Y; Li H; Yan Y; Wang K; Cheng Y; Li Y; Zhu X; Xie J; Sun X Int J Nanomedicine; 2020; 15():4691-4703. PubMed ID: 32636625 [TBL] [Abstract][Full Text] [Related]
8. Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies. Iancu SD; Albu C; Chiriac L; Moldovan R; Stefancu A; Moisoiu V; Coman V; Szabo L; Leopold N; Bálint Z Int J Nanomedicine; 2020; 15():4811-4824. PubMed ID: 32753867 [TBL] [Abstract][Full Text] [Related]
9. siRNA delivered by EGFR-specific scFv sensitizes EGFR-TKI-resistant human lung cancer cells. Lu Y; Liu L; Wang Y; Li F; Zhang J; Ye M; Zhao H; Zhang X; Zhang M; Zhao J; Yan B; Yang A; Feng H; Zhang R; Ren X Biomaterials; 2016 Jan; 76():196-207. PubMed ID: 26524539 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterisation of iron oxide nanoparticles conjugated with epidermal growth factor receptor (EGFR) monoclonal antibody as MRI contrast agent for cancer detection. Salehnia Z; Shahbazi-Gahrouei D; Akbarzadeh A; Baradaran B; Farajnia S; Naghibi M IET Nanobiotechnol; 2019 Jun; 13(4):400-406. PubMed ID: 31171745 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro. Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856 [TBL] [Abstract][Full Text] [Related]
13. Simple PEG conjugation of SPIO via an Au-S bond improves its tumor targeting potency as a novel MR tumor imaging agent. Kojima H; Mukai Y; Yoshikawa M; Kamei K; Yoshikawa T; Morita M; Inubushi T; Yamamoto TA; Yoshioka Y; Okada N; Seino S; Nakagawa S Bioconjug Chem; 2010 Jun; 21(6):1026-31. PubMed ID: 20446679 [TBL] [Abstract][Full Text] [Related]
14. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer. Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636 [TBL] [Abstract][Full Text] [Related]
15. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro. Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921 [TBL] [Abstract][Full Text] [Related]
16. Au/polypyrrole@Fe3O4 nanocomposites for MR/CT dual-modal imaging guided-photothermal therapy: an in vitro study. Feng W; Zhou X; Nie W; Chen L; Qiu K; Zhang Y; He C ACS Appl Mater Interfaces; 2015 Feb; 7(7):4354-67. PubMed ID: 25664659 [TBL] [Abstract][Full Text] [Related]
17. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging. Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916 [TBL] [Abstract][Full Text] [Related]
18. Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein. Kampmeier F; Niesen J; Koers A; Ribbert M; Brecht A; Fischer R; Kiessling F; Barth S; Thepen T Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1926-34. PubMed ID: 20449589 [TBL] [Abstract][Full Text] [Related]
19. Thiol-PEG-carboxyl-stabilized Fe₂O ₃/Au nanoparticles targeted to CD105: synthesis, characterization and application in MR imaging of tumor angiogenesis. Zhang S; Gong M; Zhang D; Yang H; Gao F; Zou L Eur J Radiol; 2014 Jul; 83(7):1190-1198. PubMed ID: 24832501 [TBL] [Abstract][Full Text] [Related]